Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tong Ren Tang Technologies Co ( (HK:1666) ) has issued an announcement.
Tong Ren Tang Technologies Co. Ltd. reported that, under PRC Accounting Standards, its group generated unaudited operating revenue of about RMB1,813.58 million and operating costs of about RMB1,109.42 million for the three months ended 31 March 2026, resulting in unaudited net profit attributable to shareholders of roughly RMB169.40 million. The group also disclosed unaudited total assets of around RMB13,846.72 million as of 31 March 2026, and advised shareholders and potential investors to exercise caution when dealing in its securities, underscoring that these are preliminary figures shared in tandem with its controlling shareholder’s Shanghai disclosure to ensure equal and timely access to financial information.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a Hong Kong-listed joint stock company incorporated in the People’s Republic of China and controlled by Beijing Tong Ren Tang Company Limited. The group operates in the traditional Chinese medicine and pharmaceutical sector, focusing on the manufacture and sale of Chinese herbal medicines and related healthcare products across domestic and overseas markets.
YTD Price Performance: -11.11%
Average Trading Volume: 1,000,911
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.02B
Find detailed analytics on 1666 stock on TipRanks’ Stock Analysis page.